ALLISON IMAHIYEROBO: Open Payments
NPI 1831406909 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 9 payments from 8 companies in 2025. Trend: 2023 $3,788 · 2024 $78 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $35 |
| Tempus AI, Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Geron Corporation | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: KEYTRUDA, XT CDX, JYNARQUE, JAKAFI, Enhertu, RYTELO, REBLOZYL.
Industry payments across NY — which companies pay providers there.
